0001209191-20-014386.txt : 20200302 0001209191-20-014386.hdr.sgml : 20200302 20200302150200 ACCESSION NUMBER: 0001209191-20-014386 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200302 FILED AS OF DATE: 20200302 DATE AS OF CHANGE: 20200302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castellanos Elaine CENTRAL INDEX KEY: 0001662520 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 20676292 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-02 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662520 Castellanos Elaine 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 VP, Chief Accounting Officer Class A common stock 2020-03-02 4 C 0 2000 A 17146 D Class A common stock 2020-03-02 4 S 0 2000 194.32 D 15146 D Employee Stock Option (right to buy) 11.00 2020-03-02 4 M 0 2000 0.00 D 2026-05-25 Class B common stock 2000 8434 D Class B common stock 2020-03-02 4 M 0 2000 11.00 A Class A common stock 2000 2000 D Class B common stock 2020-03-02 4 C 0 2000 D Class A common stock 2000 0 D The exercise, conversion, and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The options vest in sixteen equal quarterly installments beginning on August 25, 2016. /s/ Michael D. Wortley, attorney-in-fact 2020-03-02